Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.9B |
| 2 |
Boeing
BA
|
+$956M |
| 3 |
Netflix
NFLX
|
+$804M |
| 4 |
EOG Resources
EOG
|
+$761M |
| 5 |
Wells Fargo
WFC
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$1.3B |
| 2 |
Nike
NKE
|
+$1.17B |
| 3 |
AbbVie
ABBV
|
+$1.16B |
| 4 |
McDonald's
MCD
|
+$1.15B |
| 5 |
Texas Instruments
TXN
|
+$987M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.27% |
| 2 | Technology | 16.8% |
| 3 | Communication Services | 12.6% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Nutrien
NTR
$32B
| $444M | 0.13% |
9,263,802
+6,251
| +0.1% | +$302K |
|
152
Bank of Montreal
BMO
$129B
| $434M | 0.13% |
5,605,938
+1,408
| +0% | +$106K |
|
153
Suncor Energy
SU
$75.1B
| $434M | 0.13% |
13,237,456
-4,728,858
| -26% | -$148M |
|
154
Skyworks Solutions
SWKS
$10.5B
| $428M | 0.13% |
3,544,056
-2,222,062
| -39% | -$218M |
|
155
BWX Technologies
BWXT
$15.7B
| $424M | 0.13% |
6,827,427
+15,335
| +0.2% | +$911K |
|
156
Johnson & Johnson
JNJ
$630B
| $423M | 0.13% |
2,898,650
+1,566
| +0.1% | +$212K |
|
157
Alcoa
AA
$13.4B
| $418M | 0.13% |
19,452,499
+265
| +0% | +$5.49K |
|
158
Willis Towers Watson
WTW
$31.6B
| $408M | 0.12% |
2,020,130
-662,630
| -25% | -$127M |
|
159
Sempra
SRE
$56.5B
| $405M | 0.12% |
5,341,042
+474
| +0% | +$34.8K |
|
|
PARA
160
DELISTED
Paramount Global Class B
PARA
| $385M | 0.12% |
9,164,996
+2,096
| +0% | +$81.2K |
|
161
S&P Global
SPGI
$122B
| $382M | 0.11% |
1,398,044
+101,268
| +8% | +$26.3M |
|
|
GWPH
162
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $379M | 0.11% |
3,623,067
+14,697
| +0.4% | +$1.65M |
|
163
General Mills
GIS
$20.7B
| $376M | 0.11% |
7,019,587
+4,915
| +0.1% | +$259K |
|
164
Fortive
FTV
$18.5B
| $366M | 0.11% |
7,600,676
+1,130
| +0% | +$51K |
|
165
Nice
NICE
$5.89B
| $362M | 0.11% |
2,335,781
+1,076,420
| +85% | +$164M |
|
166
Equifax
EFX
$21.2B
| $359M | 0.11% |
2,560,338
+319,663
| +14% | +$44.3M |
|
|
SIX
167
DELISTED
Six Flags Entertainment Corp.
SIX
| $358M | 0.11% |
7,946,163
+823,603
| +12% | +$37.9M |
|
|
OPTU
168
Optimum Communications Inc
OPTU
$231M
| $358M | 0.11% |
13,101,519
+885
| +0% | +$24.4K |
|
|
TSG
169
DELISTED
The Stars Group Inc.
TSG
| $350M | 0.11% |
+13,421,678
| New | +$300M |
|
170
Kroger
KR
$35.1B
| $349M | 0.1% |
12,052,725
+2,013,232
| +20% | +$53.4M |
|
|
NBIS
171
Nebius Group N.V.
NBIS
$73B
| $349M | 0.1% |
8,033,480
-121,100
| -1% | -$4.52M |
|
172
PNC Financial Services
PNC
$102B
| $349M | 0.1% |
2,183,849
-404,003
| -16% | -$60.7M |
|
173
SS&C Technologies
SSNC
$18.8B
| $345M | 0.1% |
5,620,044
+1,807,278
| +47% | +$101M |
|
|
MGP
174
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $344M | 0.1% |
11,095,001
+2,068,355
| +23% | +$63.6M |
|
175
Alexandria Real Estate Equities
ARE
$8.31B
| $323M | 0.1% |
1,998,557
+601
| +0% | +$94.8K |
|
Similar funds
Capital Research Global Investors's Q4 2019 Portfolio in Review
As of Q4 2019, Capital Research Global Investors held 433 positions worth $333B, up 9.4% from $305B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q4 2019 filing shows 19 new, 239 increased, 105 reduced and 28 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M. The largest sale was Fidelity National Information Services, an estimated $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M.
- Capital Research Global Investors added most to UnitedHealth in Q4 2019, an estimated $1.9B increase.
- Capital Research Global Investors's biggest Q4 2019 reduction was Fidelity National Information Services, cutting an estimated $1.3B.
- Capital Research Global Investors fully exited 3M in Q4 2019, selling an estimated $654M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $333B portfolio in Q4 2019.
- Capital Research Global Investors opened 19 new positions and closed 28 in Q4 2019.
- Capital Research Global Investors's portfolio value rose 9.4% quarter-over-quarter to $333B.
Based on Capital Research Global Investors's 13F filing for Q4 2019, filed 18 Feb 2020.